Investigating MicroRNA expression profiles in pancreatic cystic neoplasms

Clinical and Translational Gastroenterology

Volumn 5, Issue 1, 2013, Pages

  Lee, Linda S ^a   Szafranska Schwarzbach, Anna E ^b   Wylie, Dennis ^b   Doyle, Leona A ^a   Bellizzi, Andrew M ^c   Kadiyala, Vivek ^a   Suleiman, Shadeah ^a   Banks, Peter A ^a   Andruss, Bernard F ^b   Conwell, Darwin L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ASURAGEN INC   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; MICRORNA; PARAFFIN;

ADULT; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; CYSTADENOMA; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; MUCINOUS CYSTIC NEOPLASM; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PANCREATIC CYSTIC NEOPLASM; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 84906066558     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2013.18     Document Type: Article

References (27)

1. Simeone DM. SSAT/AGA/ASGE state of the art conference on cystic neoplasms of the pancreas. J Gastrointest Surg 2008; 12: 1475-1477.
2. Fasanella KE, McGrath K. Cystic lesions and intraductal neoplasms of the pancreas. Best Pract Res Clin Gastroenterol 23 2009 35-48.
3. Lee LS, Clancy T, Kadiyala V et al. Interdisciplinary management of cystic neoplasms of the pancreas. Gastroenterol Res Pract 2012; 2012: 513163.
4. Correa-Gallego C, Ferrone CR, Thayer SP et al. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 2010; 10: 144-150.
5. Maker A, Lee LS, Raut C et al. Cytology from pancreatic cysts has marginal utility in surgical decision making. Ann Surg Oncol 2008; 15: 3187.
6. Brugge WR, Lewandrowski K, Lee-Lewandrowski E et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126: 1330-1336.
7. Van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 2005; 62: 383-389.
8. Khalid A, Zahid M, Finkelstein SD et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009; 69: 1095-1102.
9. Sawhney MS, Devarajan S, O'Farrel P et al. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest Endosc 2009; 69: 1106-1110.
10. Panarelli NC, Yantiss RK. MicroRNA expression in selected carcinomas of the gastrointestinal tract. Patholog Res Int 2011; 124608: 1-10.
11. Ichikawa D, Komatsu S, Konishi H et al. Circulating microRNA in digestive tract cancers. Gastroenterology 2012; 142: 1074-1078.
12. Szafranska AE, Davison TS, John J et al. MicroRNA expression alterations are linked to tumorigenesis and nonneoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007; 26: 4442-4452.
13. Bloomston M, Frankel WL, Petrocca F et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901-1908.
14. Lee EJ, Gusev Y, Jiang J et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 2007; 120: 1046-1054.
15. Szafranska-Schwarzbach AE, Whitcomb DC, Lloyd MB et al. A multi-center study of a microrna-based assay for the diagnosis of pancreatic ductal adenocarcinoma in fine needle aspirates. Pancreas 2011; 40: 1356.
16. Szafranska-Schwarzbach AE, Adai AT, Lee LS et al. Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma. Expert Rev Mol Diagn 2011; 11: 249-257.
17. Jiao LR, Frampton AE, Jacob J et al. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. Plos ONE 2012; 7: e32068.
18. Ryu JK, Matthaei H, dal Molin M et al. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology 2011; 11: 343-350.
19. Matthaei H, Wylie D, Lloyd MB et al. MicroRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012; 18: 4713-4724.
20. Kloppel G, Luttges J. WHO-classification 2000: exocrine pancreatic tumors. Verh Dtsch Ges Pathol 2001; 85: 219-228.
21. Dobbin KK, Zhao Y, Simon RM. How large a training set is needed to develop a classifier for microarray data? Clin Cancer Res 2008; 14: 108-114.
22. Bourgon R, Gentleman R, Huber W. Independent filtering increases detection power for high-throughput experiments. PNAS 2010; 107: 9546-9551.
23. Wylie D, Shelton J, Choudhary A et al. A novel mean-centering method for normalizing microRNA expression from high-throughput RT-qPCR data. BMC Res Notes 2011; 4: 555.
24. Jiang W, Varma S, Simon R. Calculating confidence intervals for predication error in microarray classification using resampling. Stat Appl Genet Mol Biol 2008; 7: Article8.
25. Jiao LR, Frampton AE, Jacob J et al. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. Plos ONE 2012; 7: e32068.
26. Sakorafas GH, Smyrniotis V, Reid-Lombardo KM et al. Primary pancreatic cystic neoplasms revisited. Part I: serous cystic neoplasms. Surg Oncol 2011; 20: e84-e92.
27. Tanaka M, Ferandez-del Castillo C, Adsay V et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183-197.